Biomedical Science Letters (대한의생명과학회지)

The Korean Society for Biomedical Laboratory Sciences (대한의생명과학회)
권호 표지

Septicemia Caused by Leuconostoc lactis with Intrinsic Resistance to Vancomycin in a Patient with Biliary Stent

  • Shin, Kyeong Seob (Department of Laboratory Medicine, Chungbuk National University, College of Medicine) ;
  • Han, Kyudong (Department of Nanobiomedical Science & BK21 PLUS NBM Global Research Center for Regenerative Medicine, Dankook University) ;
  • Hong, Seung Bok (Department of Clinical Laboratory Science, Chungbuk Health & Science University)
  • Received : 2013.06.19
  • Accepted : 2013.09.26
  • Published : 2013.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Leuconostoc spp. is intrinsically resistant against vancomycin and rarely causes the infection in immunocompromised patients. In this report, we describe a fatal case of Leuconostoc lactis bacteremia in a patient with biliary tract stent insertion to resolve the biliary tract obstruction by multiple pseudocysts in the pancreatic head region. Leuconostic lactis isolated from the blood of the patients was confirmed by 16S rRNA sequencing and this isolate was susceptible against most antibiotics, including levofloxacin, penicillin, erythromycin and cefotaxime except vancomycin. The septic shock and multi-organ failure was abruptly progressed due to delayed use of adequate antibiotic. Using vancomycin as the empirical antibiotics in a bacteremic patient by Gram positive cocci, the treatment failures by the isolates with intrinsic resistance against vancomycin have to be considered. In addition, the prompt and accurate identification of Leuconostoc spp. are very important to select the adequate antibiotics.

Keywords

References

  1. Aguirre M, Collins MD. Lactic acid bacteria and human infection. J Appl Bacteriol. 1993. 75: 95-107. https://doi.org/10.1111/j.1365-2672.1993.tb02753.x
  2. Cibik R, Lepage E, Talliez P. Molecular diversity of Leuconostoc mesenteroides and Leuconostoc citreum isolated from traditional French cheeses as revealed by RAPD fingerprinting, 16S rDNA sequencing and 16S rDNA fragment amplification. Syst Appl Microbiol. 2000. 23: 267-278. https://doi.org/10.1016/S0723-2020(00)80014-4
  3. Coovaida YM, Solwa Z, van den Ende J. Meningitis caused by vancomycin-resistant Leuconostoc sp. J Clin Microbiol. 1987. 25: 1784-1785.
  4. Facklam R, Elliott JA. Identification, classification, and clinical relevance of catalase-negative, Gram-positive cocci, excluding the streptococci and enterococci. Clin Microbiol Rev. 1995. 8: 479-495.
  5. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Disease Society of America. Clin Infect Dis. 2011. 52: e56-93. https://doi.org/10.1093/cid/cir073
  6. Handwerger S, Horowitz H, Coburn K, Kolokathis A, Wormser GP. Infection due to Leuconostoc sp: six cases and review. Rev Infect Dis. 1990. 12: 602-610. https://doi.org/10.1093/clinids/12.4.602
  7. Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, Feld R, Pizzo PA, Rolston KV, Shenep JL, Young LS. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002. 34: 730-751. https://doi.org/10.1086/339215
  8. Hughes WT, Armstrong D, Bodey GP, Brown AE, Edwards JE, Feld R, Pizzo PA, Rolson KV, Shenep JL, Young LS. 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Clin Infect Dis. 1997. 25: 551-573. https://doi.org/10.1086/513764
  9. Kim JG, Kim MH, Par SY, Park YJ, SUH JT, Lee HJ. A case of bacteremia caused by Leuconostoc lactis identified by 16S rRNA sequencing. Korean J Clin Microbiol. 2006. 9: 137-141.
  10. Kocak F, Yurtseven N, Aydemir N, Yuksek A, Yavuz SS. A case of osteomyelitis due to Leuconostoc lactis. Scand J Infect Dis. 2007. 39: 278-280. https://doi.org/10.1080/00365540600904811
  11. Lee MR, Huang YT, Lee PI, Liao CH, Lai CC, Lee LN, Hsueh PR. Healthcare-associated bacteremia caused by Leuconostoc species at a university hospital in Taiwan between 1995 and 2008. J Hosp Infect. 2011. 78: 45-49. https://doi.org/10.1016/j.jhin.2010.11.014
  12. Mahajan SN, Shah JN, Hachem R, Tverdek F, Adach JA, Mulanovich V, Rolston KV, Raad II, Chemaly RF. Characteristics and outcomes of methicillin-resistant Staphylococcus aureus bloodstream infections in patients with cancer treated with vancomycin: 9-year experience at a comprehensive cancer center. Oncologist 2012. 17: 1329-1336. https://doi.org/10.1634/theoncologist.2012-0029
  13. Martinez-Murcia AJ, Harland NM, Collins MD. Phylogenetic analysis of some Leuconostoc and related organisms as determined from large-subunit rRNA gene sequences: assessment of congruence of small-and large-subunit rRNA derived trees. J Appl Bacteriol. 1993. 74: 532-541.
  14. Moise-Broder PA, Sakoulas G, Eliopoulos GM, Schentag JJ, Forrest A, Moellering Jr RC. Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy. Clin Infect Dis. 2004. 38: 1700-1705. https://doi.org/10.1086/421092
  15. Rolston KV, Kapadia M, Tarrand J, Coyle E. Spectrum of Grampositive bacteremia an in vitro activities of daptomycin, linezolid and vancomycin against organisms isolated from cancer patients. Int J Antimicrob Agents. 2013. 41: 516-520. https://doi.org/10.1016/j.ijantimicag.2013.01.014
  16. Rubin LG, Shapiro J, Isenberg HD. Infection with vancomycinresistant "Streptococci" due to Leuconostoc species. J Infect Dis. 1988. 157: 216. https://doi.org/10.1093/infdis/157.1.216
  17. Swenson JM, Facklam RR, Thornsberry C. Antimicrobial susceptibility of vancomycin resistant Leuconostoc, Pediococcus, and Lactobacillus species. Antimicrob Agents Chemother. 1990. 34: 543-549. https://doi.org/10.1128/AAC.34.4.543
  18. Shin JH, Her M, Moon C, Kim D, Lee SH, Jung SJ. Leuconostoc bacteremia in a patient with amyloidosis secondary to rheumatoid arthritis and tuberculosis arthritis. Mod Reumatol. 2011. 21: 691-695. https://doi.org/10.3109/s10165-011-0465-0
  19. Starr JA. Leuconostoc species-associated endocarditis. Pharmocotherapy. 2007. 27: 766-770. https://doi.org/10.1592/phco.27.5.766
  20. Uh Y, Lee HG, Hwang GY, Yoon KJ, Yoo SY, Koo BS, Kim HY. Two cases of Leuconostoc bacteremia. Korean J Clin Microbiol. 2002. 5: 62-67.
  21. Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasm in hospitals in the United States. Clin Infect Dis. 2003. 36: 1103-1110. https://doi.org/10.1086/374339
  22. Yamazaki R, Mori T, Sugita K, Aisa Y, Ikeda Y, Okamoto S. Leuconostoc septicemia a neutropenic patient with acute myelogenous leukemia relapsed after allogenic peripheral blood stem cell transplantation. Transpl Infect Dis. 2009. 11: 94-95. https://doi.org/10.1111/j.1399-3062.2008.00340.x
  23. Youn JS, Park YJ, Kim BK, Kim SM, Shim SI. Two cases of bacteremia caused by Leuconostoc citreum. Korean J Clin Pathol. 1997. 17: 623-628.